Iclepertin: GlyT1 inhibitor
Iclepertin: GlyT1 inhibitor
Search
The ANGELS infographic showcasing global stroke care improvements.pdf
C3-binding polypeptide
C3-binding polypeptide
Global Network | Bioxcellence | Boehringer Ingelheim
Our network of manufacturing facilities spans the globe, from Fremont, in the United States to Biberach in Germany, Vienna in Austria and Shanghai in China
Infographic: ANGELS Initiative
C3-binding polypeptide
Partnering in Mental Health Disorders HP OCTOBER 2024 CORP.pdf
Partnering in Cardio-Renal-Metabolic HP OCTOBER 2024 CORP.pdf
Partnering in Immunology & Resp HP OCTOBER 2024 CORP.pdf
Angels_SD4G_Infografik_2024_Final.pdf
Human Health Partnering Interests
Human Health Partnering Interests
Boehringer Ingelheim - Life Forward
Learn how we change life for the better for people and animals.
Why cancer care is personal for us
At Boehringer Ingelheim, we have made a generational commitment to transforming cancer care, with the ultimate goal of curing a range of cancers.
Isabel
In this video, Isabel shares how watching her children and grandchildren grow up inspires her to take the necessary steps to manage her life with type 2 diabetes and heart disease.
Equestrian sports horse health awareness Alex Hua Tian
Together with Olympian trailblazer and eventer Alex Hua Tian, we educate about equine health in China.
Diabetes dog symptoms chronic disease management
Learn about the symptoms of canine diabetes and how to manage the disease.
Julia Sonnermann
Julia Sonnermann on transforming lives for generations
Matthias Mayer
Matthias Mayer sees strengths in differences
Registration Microbial Expert Workshop
Connect with our microbial specialists in Boston
Brigitte Fuhr
Brigitte Fuhr on constant innovation
SENVELGO Best New Product Companion Animals award
SENVELGO won the 2023 Animal Health Best New Product for Companion Animals award
Life forward
In everything we do we can shape and influence the future for the better: Learn more about “Life forward” and how our innovations improve lives.
Connect the Docs
Experts discuss interconnectivitiy of heart failure, diabetes, and kidney disease and the importance of early diagnosis.
Cancer's Big 4
We have a robust pipeline of clinical assets including cancer cell-directed therapies, for which we are investigating the key drivers of cancer such as P53 and KRAS.
Circular economy
Boehringer Ingelheim strives to use resources for as long as possible, process them for reuse or recycle them.